Table 3 Risk factors for HBV reactivation.

From: Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation

 

Univariate

Multivariate

HR (95% CI)

P-value

HR (95% CI)

P-value

Rejection

2.731 (0.653, 11.429)

0.169

  

Use of ATG

1.509 (0.183, 12.429)

0.702

  

Standard dose rituximab

8.256 (1.973, 34.551)

0.004

10.598 (2.519, 44.599)

0.001

anti-HBs ≥ 100 IU/L

0.149 (0.018, 1.214)

0.075

0.11 (0.013, 0.905)

0.04

Donor anti-HBc (+)

0.652 (0.132, 3.230)

0.600

  

Causes of rituximab

0.885 (0.148, 5.297)

0.893

  

Number of plasmapheresis

1.343 (0.862, 1.913)

0.314

  

Tacrolimus trough level

0.899 (0.652, 1.240)

0.516

  

MMF dose

1.001 (0.999,1.002)

0.280

  
Back to article page